Surgical challenges of giant parathyroid adenomas weighing 10 g or more

J Endocrinol Invest. 2023 Jun;46(6):1169-1176. doi: 10.1007/s40618-022-01968-3. Epub 2022 Dec 24.

Abstract

Purpose: An average parathyroid adenoma (PA) weighs < 1 g. This study aimed to characterise giant PAs ≥ 10 g (GPAs) to facilitate surgical management of primary hyperparathyroidism (PHPT).

Methods: All patients with a GPA confirmed on histology were recruited from the Monash University Endocrine Surgery Unit database. Clinical and demographic data were collected and compared to a group of non-GPA patients.

Results: A total of 14 GPAs were identified between 2007 and 2018 out of 863 patients (1.6%) with a single PA excised for PHPT. The GPA patients were compared to a control group of 849 non-GPA patients in the same period with similar mean age (62 ± 16 vs 63 ± 14, P = 0.66) and gender distribution (64% vs 75% female, P = 0.35). Pre-operative calcium (Ca) and parathyroid hormone (PTH) levels were significantly higher in GPA patients (P < 0.001). A higher percentage of GPA patients (79%) had concordant localisation studies (ultrasound and sestamibi) than control patients (59%), (P = 0.13), but they were significantly less likely to undergo MIP (55% vs 82%, P = 0.02). The median GPA weighed 12.5 g (IQR 10.5-24.3). Median serum Ca normalised by day 1 post-operatively, while PTH remained elevated. Both serum Ca and PTH levels were in the normal range at 3 months. All GPA lesions were benign on histopathology.

Conclusion: GPAs are rare and display severe clinical and biochemical abnormalities. Despite their large size, concordant pre-operative imaging was not always achieved, and a few patients were suitable for MIP.

Keywords: Giant parathyroid adenoma; Parathyroid adenoma; Primary hyperparathyroidism.

MeSH terms

  • Adenoma* / surgery
  • Female
  • Humans
  • Hyperparathyroidism, Primary* / diagnosis
  • Hyperparathyroidism, Primary* / surgery
  • Male
  • Parathyroid Hormone
  • Parathyroid Neoplasms* / pathology
  • Parathyroid Neoplasms* / surgery
  • Parathyroidectomy / methods
  • Technetium Tc 99m Sestamibi

Substances

  • Technetium Tc 99m Sestamibi
  • Parathyroid Hormone